OUTLOOK THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Increase (Decrease) in Accounts Receivable of $153.36 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-18
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$1.08M.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $2.61M.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$1.38M.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$260.49K.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2025 was $1.49M.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2016 was -$20.00K, a 200.00% decline from fiscal 2015.
- OUTLOOK THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2015 was $20.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-18 | $1.53M derived: sum of 2 quarters · filed 2026-08-18 | $153.36K 10-Q · filed 2026-08-18 | -$107.13K derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-03-31 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | $1.23M 10-Q · filed 2026-05-15 | $968.41K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | -$1.38M 10-Q · filed 2026-02-17 | -$1.64M derived: sum of 2 quarters · filed 2026-02-17 | ||
| 2025-09-30 | -$260.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | $1.49M 10-K · filed 2025-12-19 | ||
| 2025-06-30 | $1.75M 10-Q · filed 2026-08-18 | |||
| 2016-09-30 | -$3.67K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | -$504.86K derived: sum of 2 quarters · filed 2017-12-29 | -$103.09K derived: sum of 3 quarters · filed 2017-12-29 | -$20.00K 10-K · filed 2017-12-29 |
| 2016-06-30 | -$501.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | -$99.42K derived: sum of 2 quarters · filed 2017-08-14 | -$16.33K 10-Q · filed 2017-08-14 | -$69.24K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $401.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | $484.86K 10-Q · filed 2017-05-15 | $431.95K derived: sum of 3 quarters · filed 2017-05-15 | -$568.05K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $83.09K 10-Q · filed 2017-02-14 | $30.18K derived: sum of 2 quarters · filed 2017-02-14 | -$969.82K derived: sum of 3 quarters · filed 2017-02-14 | |
| 2015-09-30 | -$52.91K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-29 | -$1.05M derived: sum of 2 quarters · filed 2016-12-29 | $20.00K 10-K · filed 2016-12-29 | |
| 2015-06-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | $72.91K 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $1.07M 10-Q · filed 2016-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |